<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04849975</url>
  </required_header>
  <id_info>
    <org_study_id>38RC21.001</org_study_id>
    <nct_id>NCT04849975</nct_id>
  </id_info>
  <brief_title>Comparison of Pelvimetric Measurements Between MRI and Low-dose Stereoradiography (EOS® Imaging System)</brief_title>
  <acronym>CAPEOS®</acronym>
  <official_title>Comparison of Pelvimetric Measurements Between MRI and Low-dose Stereoradiography (EOS® Imaging System)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to compare pelvimetric measurements performed by Magnetic&#xD;
      Resonance Imaging (MRI) and by the EOS imaging system.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During pregnancy, after failure of External Manual Version (EMV) in case of breech fetal&#xD;
      presentation, a radiological pelvimetry is performed to evaluate the measurements of the&#xD;
      pelvis and decide on the appropriate mode of delivery.&#xD;
&#xD;
      Several imaging modalities are used, including pelvic computed tomography (CT),and magnetic&#xD;
      resonance imaging (MRI) of the pelvis.&#xD;
&#xD;
      CT scan has the disadvantage of maternal irradiation and MRI has the disadvantage of an&#xD;
      inaccurate morphological analysis.The EOS® system is an imaging tool used in radiopediatric&#xD;
      to allow precise morphological analysis of bone masses with minimal irradiation.&#xD;
&#xD;
      The quality of the morphological analysis and measurements provided by the EOS® imaging&#xD;
      system is the reason for proposing this study comparing the pelvimetric measurements obtained&#xD;
      by MRI and by the EOS® imaging system.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 9, 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Estimation of the reliability of pelvimetric measurements using Transverse Inlet Diameter measurement</measure>
    <time_frame>Up to 1 day</time_frame>
    <description>Transverse Inlet Diameter Measurement obtained by EOS® system versus MRI is evaluated in millimeters.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimation of the reliability of pelvimetric measurements using ante posterior diameter measurement</measure>
    <time_frame>Up to 1 day</time_frame>
    <description>Ante posterior diameter of the pelvic inlet obtained by using EOS® system versus MRI is evaluated in millimeters.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimation of the reliability of pelvimetric measurements using BiSpinous Diameter measurement</measure>
    <time_frame>Up to 1 day</time_frame>
    <description>BiSpinous Diameter obtained by EOS® system versus MRI is evaluated in millimeters.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimation of the reliability of pelvimetric measurements using Bi-ischiatic mesurement</measure>
    <time_frame>Up to 1 day</time_frame>
    <description>Bi-ischiatic measurement obtained by EOS® system versus MRI is evaluated in millimeters.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimation of the reliability of pelvimetric measurements using Magin's Index calculation</measure>
    <time_frame>Up to 1 day</time_frame>
    <description>Magnin's Index calculation obtained by using EOS® system versus MRI is evaluated in millimeters.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pelvis morphological description using Cadwell and Moloy classification</measure>
    <time_frame>Up to 1 day</time_frame>
    <description>Caldwell and Moloy classification (scale) obtained by MRI and EOS® system is qualified.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvis morphological description using subpubic angle measurement</measure>
    <time_frame>Up to 1 day</time_frame>
    <description>The measurement of the subpubic angle (in degree) obtained by MRI and EOS® system is qualified.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvis morphological description using obturating holes appearance</measure>
    <time_frame>Up to 1 day</time_frame>
    <description>The appearance of the obturating holes (descriptive analysis) obtained by MRI and EOS® system is qualified.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Characterization of fetal and maternal radiation doses received by EOS® system.</measure>
    <time_frame>Up to 1 day</time_frame>
    <description>Estimation of maternal and fetal irradiation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the intra and inter-observer reproducibility for radiological interpretation</measure>
    <time_frame>4 days</time_frame>
    <description>Blind independent reading of MRI and EOS® images by two radiologists on two different days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the intra and inter-observer reproducibility for clinical interpretation</measure>
    <time_frame>4 days</time_frame>
    <description>Blind independent reading of MRI and EOS® images by two independent clinician on two different days with conclusion on the mode of delivery.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Breech Fetal Presentation</condition>
  <arm_group>
    <arm_group_label>Pelvimetry group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participants oh this group will successively perform MRI pelvimetry and EOS imaging.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pelvimetric measurements</intervention_name>
    <description>The patients in this group are pregnant women after failure of external manual version (EMV) in case of breech fetal presentation. The participants will successively perform MRI pelvimetry (conventional management) and EOS imaging.</description>
    <arm_group_label>Pelvimetry group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients &gt; 18 years of age&#xD;
&#xD;
          -  Patient requiring pelvimetry (breech fetus)&#xD;
&#xD;
          -  Gestation &gt; 36 SA (weeks of amenorrhea)&#xD;
&#xD;
          -  Patients with BMI &lt; 30&#xD;
&#xD;
          -  Affiliated to social security or similarly regime&#xD;
&#xD;
          -  Patients who gave their consent to participate in the study (Patient having agreed to&#xD;
             perform both examinations: MRI and EOS system)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with a contraindication to MRI (claustrophobia, pace-maker, intracorporeal&#xD;
             metallic element)&#xD;
&#xD;
          -  Patient with a contraindication to performing EOS® (person not standing alone)&#xD;
&#xD;
          -  Patient who are in exlusion period of another interventiionnal study&#xD;
&#xD;
          -  Person deprived of freedom by judicial or administrative decision; person hospitalized&#xD;
             for psychitric care; person under legal protection measure.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Didier R RIETHMULLER, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Grenoble</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Didier R RIETHMULLER, MD, PhD</last_name>
    <phone>+33476765400</phone>
    <email>driethmuller@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isabelle Boudry, PhD</last_name>
    <phone>+33476766645</phone>
    <email>iboudry@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pr Riethmuller Didier</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier RIETHMULLER, MD, PhD</last_name>
      <phone>+33476765400</phone>
      <email>driethmuller@chu-grenoble.fr</email>
    </contact>
    <contact_backup>
      <last_name>Isabelle Boudry, PhD</last_name>
      <phone>+33476766645</phone>
      <email>iboudry@chu-grenoble.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Marie Caroline Faisant, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Aubry S, Padoin P, Petegnief Y, Vidal C, Riethmuller D, Delabrousse E. Can three-dimensional pelvimetry using low-dose stereoradiography replace low-dose CT pelvimetry? Diagn Interv Imaging. 2018 Sep;99(9):569-576. doi: 10.1016/j.diii.2018.02.008. Epub 2018 Mar 19.</citation>
    <PMID>29567122</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>March 11, 2021</study_first_submitted>
  <study_first_submitted_qc>April 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2021</study_first_posted>
  <last_update_submitted>November 10, 2021</last_update_submitted>
  <last_update_submitted_qc>November 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breech Fetal Presentation</keyword>
  <keyword>MRI</keyword>
  <keyword>EOS imaging system</keyword>
  <keyword>Pelvimetric measurements</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breech Presentation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

